Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: Association between CHEK2 H371Y mutation and response to neoadjuvant chemotherapy in women with breast cancer

Figure 1

Kaplan-Meier Estimates of distant recurrence-free survival by pCR andCHEK2H371Y mutation status in 2334 breast cancer patients who received neoadjuvant chemotherapy. Distant recurrence-free survival by pCR status (A); Distant recurrence-free survival by CHEK2 H371Y mutation status (B); Distant recurrence-free survival by pCR and CHEK2 H371Y mutation status (C).

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us